International Stem Cell Corp. (OTCMKTS:ISCO – Get Free Report)’s share price passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.14 and traded as high as $0.16. International Stem Cell shares last traded at $0.1410, with a volume of 10,604 shares changing hands.
International Stem Cell Stock Performance
The company has a market cap of $1.13 million, a price-to-earnings ratio of -3.53 and a beta of -0.03. The business’s 50 day moving average price is $0.14 and its 200-day moving average price is $0.14.
International Stem Cell (OTCMKTS:ISCO – Get Free Report) last issued its earnings results on Thursday, August 14th. The biotechnology company reported $0.01 earnings per share for the quarter. The business had revenue of $2.45 million for the quarter.
International Stem Cell Company Profile
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Featured Stories
- Five stocks we like better than International Stem Cell
- What Does Downgrade Mean in Investing?
- Is Robinhood’s 11% Post-Earnings Fall a Buy-the-Dip Opportunity?
- How Investors Can Find the Best Cheap Dividend Stocks
- AI Demand Is Coming—Is Microchip Technology Ready?
- 3 Healthcare Dividend Stocks to Buy
- Why Investors Have Flocked to 2 Unorthodox ETFs This Month
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
